Cingulate Inc., a company listed on the United States Securities and Exchange Commission, has announced a Special Meeting of Stockholders to be held virtually on August 23, 2024. The primary agenda for the meeting is to seek stockholder approval for two key proposals. The first, known as the Issuance Proposal, is to authorize the issuance of shares of common stock underlying certain warrants as part of compliance with Nasdaq Listing Rule 5635(d). These warrants were issued pursuant to an Inducement Letter dated June 28, 2024, and an Engagement Letter with H.C. Wainwright & Co., LLC, dated December 27, 2023. The second proposal, the Adjournment Proposal, is to approve the adjournment of the Special Meeting to a later date if necessary, to allow for further solicitation of...Show More

Cingulate Inc., a company listed on the United States Securities and Exchange Commission, has announced a Special Meeting of Stockholders to be held virtually on August 23, 2024. The primary agenda for the meeting is to seek stockholder approval for two key proposals. The first, known as the Issuance Proposal, is to authorize the issuance of shares of common stock underlying certain warrants as part of compliance with Nasdaq Listing Rule 5635(d). These warrants were issued pursuant to an Inducement Letter dated June 28, 2024, and an Engagement Letter with H.C. Wainwright & Co., LLC, dated December 27, 2023. The second proposal, the Adjournment Proposal, is to approve the adjournment of the Special Meeting to a later date if necessary, to allow for further solicitation of proxies if there are insufficient votes for the Issuance Proposal. The Board of Directors has unanimously recommended voting in favor of both proposals. Stockholders as of the record date, June 28, 2024, are entitled to vote and have been provided with various methods to submit their proxy votes. The company emphasizes the importance of stockholder votes and has provided detailed instructions for voting by mail, telephone, or internet. The results of the voting will be published in a Current Report on Form 8-K within four business days of the Special Meeting.